This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Nephros’s 8K filing here.
Nephros Company Profile
Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.
See Also
- Five stocks we like better than Nephros
- EV Stocks and How to Profit from Them
- Rocket Lab is the Right Stock for the Right Time
- Dividend Payout Ratio Calculator
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
